Related references
Note: Only part of the references are listed.Interleukin-35: a Potential Therapeutic Agent for Autoimmune Diseases
Shi-Yang Guan et al.
INFLAMMATION (2017)
Cutting Edge: IL-36 Receptor Promotes Resolution of Intestinal Damage
Oscar Medina-Contreras et al.
JOURNAL OF IMMUNOLOGY (2016)
IL-33 Drives Eosinophil Infiltration and Pathogenic Type 2 Helper T-Cell Immune Responses Leading to Chronic Experimental Ileitis
Carlo De Salvo et al.
AMERICAN JOURNAL OF PATHOLOGY (2016)
Soluble ST2 is a sensitive clinical marker of ulcerative colitis evolution
David Diaz-Jimenez et al.
BMC GASTROENTEROLOGY (2016)
Epidermal growth factor is a critical regulator of the cytokine IL-33 in intestinal epithelial cells
M. S. Islam et al.
BRITISH JOURNAL OF PHARMACOLOGY (2016)
Distinct expression of interleukin (IL)-36α, β and γ, their antagonist IL-36Ra and IL-38 in psoriasis, rheumatoid arthritis and Crohn's disease
M. -A. Boutet et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2016)
Effectiveness and Safety of Vedolizumab Induction Therapy for Patients With Inflammatory Bowel Disease
Aurelien Amiot et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2016)
Cytokines and intestinal inflammation
Giorgos Bamias et al.
CURRENT OPINION IN GASTROENTEROLOGY (2016)
Interleukin-33, friend and foe in type-2 immune responses
Clare Hardman et al.
CURRENT OPINION IN IMMUNOLOGY (2016)
Suppression of innate inflammation and immunity by interleukin-37
Charles A. Dinarello et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2016)
Anti- TNF- a therapies for the treatment of Crohn's disease: the past, present and future
Marc Berns et al.
EXPERT OPINION ON INVESTIGATIONAL DRUGS (2016)
Interleukin 27 is up-regulated in patients with active inflammatory bowel disease
Janette Furuzawa Carballeda et al.
IMMUNOLOGIC RESEARCH (2016)
A Multicenter, Double-Blind, Placebo-Controlled Phase3 Study of Ustekinumab, a Human IL-12/23P40 mAB, in Moderate-Service Crohn's Disease Refractory to Anti-TFNα: UNITI-1
William Sandborn et al.
INFLAMMATORY BOWEL DISEASES (2016)
Cytokine Networks and T-Cell Subsets in Inflammatory Bowel Diseases
Mei Lan Chen et al.
INFLAMMATORY BOWEL DISEASES (2016)
Interleukin-27 as a Novel Therapy for Inflammatory Bowel Disease: A Critical Review of the Literature
Caroline Andrews et al.
INFLAMMATORY BOWEL DISEASES (2016)
Increased Expression of Interleukin-36, a Member of the Interleukin-1 Cytokine Family, in Inflammatory Bowel Disease
Atsushi Nishida et al.
INFLAMMATORY BOWEL DISEASES (2016)
Multi-Center Experience of Vedolizumab Effectiveness in Pediatric Inflammatory Bowel Disease
Namita Singh et al.
INFLAMMATORY BOWEL DISEASES (2016)
IL23R (Interleukin 23 Receptor) Variants Protective against Inflammatory Bowel Diseases (IBD) Display Loss of Function due to Impaired Protein Stability and Intracellular Trafficking
Durga Sivanesan et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2016)
IL-36α expression is elevated in ulcerative colitis and promotes colonic inflammation
S. E. Russell et al.
MUCOSAL IMMUNOLOGY (2016)
Loss of interleukin 33 expression in colonic crypts - a potential marker for disease remission in ulcerative colitis
Mona Dixon Gundersen et al.
SCIENTIFIC REPORTS (2016)
Advances in the development of new biologics in inflammatory bowel disease
Bella Ungar et al.
ANNALS OF GASTROENTEROLOGY (2016)
IL-37b gene transfer enhances the therapeutic efficacy of mesenchumal stromal cells in DSS-induced colitis mice
Wei-qiang Wang et al.
ACTA PHARMACOLOGICA SINICA (2015)
The Immunobiology of Interleukin-27
Hiroki Yoshida et al.
ANNUAL REVIEW OF IMMUNOLOGY VOL 33 (2015)
Insights into IL-37, the role in autoimmune diseases
Wang-Dong Xu et al.
AUTOIMMUNITY REVIEWS (2015)
IL-27-induced modulation of autoimmunity and its therapeutic potential
Rakeshchandra R. Meka et al.
AUTOIMMUNITY REVIEWS (2015)
Interleukin 12 (IL-12) family cytokines: Role in immune pathogenesis and treatment of CNS autoimmune disease
Lin Sun et al.
CYTOKINE (2015)
Interleukin 35 (IL-35) and IL-37: Intestinal and peripheral expression by T and B regulatory cells in patients with Inflammatory Bowel Disease
Gabriela Fonseca-Camarillo et al.
CYTOKINE (2015)
The interleukin (IL)-1 cytokine family - Balance between agonists and antagonists in inflammatory diseases
Jennifer Palomo et al.
CYTOKINE (2015)
Interleukin 35: Critical regulator of immunity and lymphocyte-mediated diseases
Charles E. Egwuagu et al.
CYTOKINE & GROWTH FACTOR REVIEWS (2015)
Anrukinzumab, an anti-interleukin 13 monoclonal antibody, in active UC: efficacy and safety from a phase IIa randomised multicentre study
Walter Reinisch et al.
GUT (2015)
Briakinumab for Treatment of Crohn's Disease: Results of a Randomized Trial
Remo Panaccione et al.
INFLAMMATORY BOWEL DISEASES (2015)
IL-33 alleviates DSS-induced chronic colitis in C57BL/6 mice colon lamina propria by suppressing Th17 cell response as well as Th1 cell response
Junfeng Zhu et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2015)
IL-33 Aggravates DSS-Induced Acute Colitis in Mouse Colon Lamina Propria by Enhancing Th2 Cell Responses
Junfeng Zhu et al.
MEDIATORS OF INFLAMMATION (2015)
Immunopathogenesis of IBD: current state of the art
Heitor S. P. de Souza et al.
Nature Reviews Gastroenterology & Hepatology (2015)
Mongersen, an Oral SMAD7 Antisense Oligonucleotide, and Crohn's Disease
Giovanni Monteleone et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
IL-33 promotes an innate immune pathway of intestinal tissue protection dependent on amphiregulin-EGFR interactions
Laurel A. Monticelli et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2015)
Inflammatory bowel disease: genetics, epigenetics, and pathogenesis
Italia Loddo et al.
FRONTIERS IN IMMUNOLOGY (2015)
Tralokinumab for moderate-to-severe UC: a randomised, double-blind, placebo-controlled, phase IIa study
Silvio Danese et al.
GUT (2015)
Oral Delivery of IL-27 Recombinant Bacteria Attenuates Immune Colitis in Mice
Miranda L. Hanson et al.
GASTROENTEROLOGY (2014)
Intestinal Expression of the Anti-Inflammatory Interleukin-1 Homologue IL-37 in Pediatric Inflammatory Bowel Disease
Simon Weidlich et al.
JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION (2014)
IL-27, targeting antigen-presenting cells, promotes Th17 differentiation and colitis in mice
A. Visperas et al.
MUCOSAL IMMUNOLOGY (2014)
The alarmin IL-33 promotes regulatory T-cell function in the intestine
Chris Schiering et al.
NATURE (2014)
The Possible Role of the Novel Cytokines IL-35 and IL-37 in Inflammatory Bowel Disease
Yanmei Li et al.
MEDIATORS OF INFLAMMATION (2014)
Cytokines in inflammatory bowel disease
Markus F. Neurath
NATURE REVIEWS IMMUNOLOGY (2014)
Epithelial expression of interleukin-37b in inflammatory bowel disease
H. Imaeda et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2013)
Neutralisation of the interleukin-33/ST2 pathway ameliorates experimental colitis through enhancement of mucosal healing in mice
Mamdouh A. K. Sedhom et al.
GUT (2013)
The Interleukin-1 Family: Back to the Future
Cecilia Garlanda et al.
IMMUNITY (2013)
Interleukin-33 exacerbates acute colitis via interleukin-4 in mice
Peter N. Pushparaj et al.
IMMUNOLOGY (2013)
The Role of IL-33 in Gut Mucosal Inflammation
Luca Pastorelli et al.
MEDIATORS OF INFLAMMATION (2013)
Associations between Genetic Polymorphisms in IL-33, IL1R1 and Risk for Inflammatory Bowel Disease
Anna Latiano et al.
PLOS ONE (2013)
Biology of IL-36 cytokines and their role in disease
Mark S. Gresnigt et al.
SEMINARS IN IMMUNOLOGY (2013)
Targeting IL-23 by employing a p40 peptide-based vaccine ameliorates murine allergic skin and airway inflammation
Q. Guan et al.
CLINICAL AND EXPERIMENTAL ALLERGY (2012)
Expression of IL-1Rrp2 by human myelomonocytic cells is unique to DCs and facilitates DC maturation by IL-1F8 and IL-1F9
Shilla Mutamba et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2012)
Interleukin-33 Ameliorates Experimental Colitis through Promoting Th2/Foxp3+ Regulatory T-Cell Responses in Mice
Lihua Duan et al.
MOLECULAR MEDICINE (2012)
IL-12 family cytokines: immunological playmakers
Dario A. A. Vignali et al.
NATURE IMMUNOLOGY (2012)
Tofacitinib, an Oral Janus Kinase Inhibitor, in Active Ulcerative Colitis
William J. Sandborn et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Treatment with IL-27 attenuates experimental colitis through the suppression of the development of IL-17-producing T helper cells
Tetsumasa Sasaoka et al.
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY (2011)
IL-36R ligands are potent regulators of dendritic and T cells
Solenne Vigne et al.
BLOOD (2011)
Interleukin-35 Mediates Mucosal Immune Responses That Protect Against T-Cell-Dependent Colitis
Stefan Wirtz et al.
GASTROENTEROLOGY (2011)
IL-27 promotes T cell-dependent colitis through multiple mechanisms
Jennifer H. Cox et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2011)
Inter-Regulation of Th17 Cytokines and the IL-36 Cytokines In Vitro and In Vivo: Implications in Psoriasis Pathogenesis
Yijun Carrier et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2011)
Targeting IL-12/IL-23 by Employing a p40 Peptide-Based Vaccine Ameliorates TNBS-Induced Acute and Chronic Murine Colitis
Qingdong Guan et al.
MOLECULAR MEDICINE (2011)
Interleukin 37 expression protects mice from colitis
Eoin N. McNamee et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Inflammatory Bowel Disease
Arthur Kaser et al.
ANNUAL REVIEW OF IMMUNOLOGY, VOL 28 (2010)
Signal transduction pathways and transcriptional regulation in Th17 cell differentiation
Kiyoshi Hirahara et al.
CYTOKINE & GROWTH FACTOR REVIEWS (2010)
Targeting IL-23 in human diseases
Mario M. D'Elios et al.
EXPERT OPINION ON THERAPEUTIC TARGETS (2010)
Interleukin-23 Drives Intestinal Inflammation through Direct Activity on T Cells
Philip P. Ahern et al.
IMMUNITY (2010)
Characterization of the Novel ST2/IL-33 System in Patients with Inflammatory Bowel Disease
Carol J. Beltran et al.
INFLAMMATORY BOWEL DISEASES (2010)
Interleukin-33 expression is specifically enhanced in inflamed mucosa of ulcerative colitis
Ayako Kobori et al.
JOURNAL OF GASTROENTEROLOGY (2010)
Inflammatory Bowel Disease
Eva Szigethy et al.
CHILD AND ADOLESCENT PSYCHIATRIC CLINICS OF NORTH AMERICA (2010)
Overview of biologic therapy for Crohn's disease
Gerald W. Dryden
EXPERT OPINION ON BIOLOGICAL THERAPY (2009)
Th1/Th17 Immune Response Is Induced by Mesenteric Lymph Node Dendritic Cells in Crohn's Disease
Atsushi Sakuraba et al.
GASTROENTEROLOGY (2009)
IL-27 Regulates Homeostasis of the Intestinal CD4+ Effector T Cell Pool and Limits Intestinal Inflammation in a Murine Model of Colitis
Amy E. Troy et al.
JOURNAL OF IMMUNOLOGY (2009)
Development of recombinant vaccines against IL-12/IL-23 p40 and in vivo evaluation of their effects in the downregulation of intestinal inflammation in murine colitis
Qingdong Guan et al.
VACCINE (2009)
A randomized trial of ustekinumab, a human interleukin-12/23 monoclonal antibody, in patients with moderate-to-severe Crohn's disease
William J. Sandborn et al.
GASTROENTEROLOGY (2008)
IL23 differentially regulates the Th1/Th17 balance in ulcerative colitis and Crohn's disease
T. Kobayashi et al.
GUT (2008)
Transcriptional regulation of Th17 cell differentiation
Ivaylo I. Ivanov et al.
SEMINARS IN IMMUNOLOGY (2007)
Immunologic and molecular mechanisms in inflammatory bowel disease
M. Nedim Ince et al.
SURGICAL CLINICS OF NORTH AMERICA (2007)
A genome-wide association study identifies IL23R as an inflammatory bowel disease gene
Richard H. Duerr et al.
SCIENCE (2006)
Interleukin-23 drives innate and T cell-mediated intestinal inflammation
Sophie Hue et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2006)
IL-23 plays a key role in Helicobacter hepaticus-induced T cell-dependent colitis
Marika C. Kullberg et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2006)
IL-23 is essential for T cell-mediated colitis and promotes inflammation via IL-17 and IL-6
D Yen et al.
JOURNAL OF CLINICAL INVESTIGATION (2006)
Evolving knowledge and therapy of inflammatory bowel disease
JR Korzenik et al.
NATURE REVIEWS DRUG DISCOVERY (2006)
New concepts in the pathophysiology of inflammatory bowel disease
G Bamias et al.
ANNALS OF INTERNAL MEDICINE (2005)
New IL-12-family members: IL-23 and IL-27, cytokines with divergent functions
CA Hunter
NATURE REVIEWS IMMUNOLOGY (2005)
Expression of interleukin-12-related cytokine transcripts in inflammatory bowel disease: Elevated interleukin-23p19 and interleukin-27p28 in Crohn's disease but not in ulcerative colitis
C Schmidt et al.
INFLAMMATORY BOWEL DISEASES (2005)
Interleukin-1 homologues lL-1F7b and IL-18 contain functional mRNA instability elements within the coding region responsive to lipopolysaccharide
P Bufler et al.
BIOCHEMICAL JOURNAL (2004)
IL-12 and IL-23: master regulators of innate and adaptive immunity
CL Langrish et al.
IMMUNOLOGICAL REVIEWS (2004)
Anti-interleukin-12 antibody for active Crohn's disease
PJ Mannon et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
New cytokine therapeutics for inflammatory bowel disease
PCF Stokkers et al.
CYTOKINE (2004)
Clinical epidemiology of inflammatory bowel disease: Incidence, prevalence, and environmental influences
EV Loftus
GASTROENTEROLOGY (2004)
Interleukin-12 and the regulation of innate resistance and adaptive immunity
G Trinchieri
NATURE REVIEWS IMMUNOLOGY (2003)
Share Paper
